These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26472355)

  • 1. Gift from Nature: Cyclomarin A Kills Mycobacteria and Malaria Parasites by Distinct Modes of Action.
    Bürstner N; Roggo S; Ostermann N; Blank J; Delmas C; Freuler F; Gerhartz B; Hinniger A; Hoepfner D; Liechty B; Mihalic M; Murphy J; Pistorius D; Rottmann M; Thomas JR; Schirle M; Schmitt EK
    Chembiochem; 2015 Nov; 16(17):2433-6. PubMed ID: 26472355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of New Cyclomarin Derivatives and Their Biological Evaluation towards Mycobacterium Tuberculosis and Plasmodium Falciparum.
    Kiefer A; Bader CD; Held J; Esser A; Rybniker J; Empting M; Müller R; Kazmaier U
    Chemistry; 2019 Jul; 25(37):8894-8902. PubMed ID: 31012978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural product cyclomarin kills Mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease.
    Schmitt EK; Riwanto M; Sambandamurthy V; Roggo S; Miault C; Zwingelstein C; Krastel P; Noble C; Beer D; Rao SP; Au M; Niyomrattanakit P; Lim V; Zheng J; Jeffery D; Pethe K; Camacho LR
    Angew Chem Int Ed Engl; 2011 Jun; 50(26):5889-91. PubMed ID: 21563281
    [No Abstract]   [Full Text] [Related]  

  • 4. Structural basis of mycobacterial inhibition by cyclomarin A.
    Vasudevan D; Rao SP; Noble CG
    J Biol Chem; 2013 Oct; 288(43):30883-91. PubMed ID: 24022489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of diverse natural products as falcipain-2 inhibitors through structure-based virtual screening.
    Wang L; Zhang S; Zhu J; Zhu L; Liu X; Shan L; Huang J; Zhang W; Li H
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1261-4. PubMed ID: 24530004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibiotic cyclomarin blocks arginine-phosphate-induced millisecond dynamics in the N-terminal domain of ClpC1 from
    Weinhäupl K; Brennich M; Kazmaier U; Lelievre J; Ballell L; Goldberg A; Schanda P; Fraga H
    J Biol Chem; 2018 Jun; 293(22):8379-8393. PubMed ID: 29632076
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent Developments on the Synthesis and Bioactivity of Ilamycins/Rufomycins and Cyclomarins, Marine Cyclopeptides That Demonstrate Anti-Malaria and Anti-Tuberculosis Activity.
    Kazmaier U; Junk L
    Mar Drugs; 2021 Aug; 19(8):. PubMed ID: 34436284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clp-targeting BacPROTACs impair mycobacterial proteostasis and survival.
    Hoi DM; Junker S; Junk L; Schwechel K; Fischel K; Podlesainski D; Hawkins PME; van Geelen L; Kaschani F; Leodolter J; Morreale FE; Kleine S; Guha S; Rumpel K; Schmiedel VM; Weinstabl H; Meinhart A; Payne RJ; Kaiser M; Hartl M; Boehmelt G; Kazmaier U; Kalscheuer R; Clausen T
    Cell; 2023 May; 186(10):2176-2192.e22. PubMed ID: 37137307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total synthesis of cyclomarins A, C and D, marine cyclic peptides with interesting anti-tuberculosis and anti-malaria activities.
    Barbie P; Kazmaier U
    Org Biomol Chem; 2016 Jul; 14(25):6036-54. PubMed ID: 27241518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional attributes of malaria parasite diadenosine tetraphosphate hydrolase.
    Sharma A; Yogavel M; Sharma A
    Sci Rep; 2016 Feb; 6():19981. PubMed ID: 26829485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads.
    Wolf NM; Lee H; Choules MP; Pauli GF; Phansalkar R; Anderson JR; Gao W; Ren J; Santarsiero BD; Lee H; Cheng J; Jin YY; Ho NA; Duc NM; Suh JW; Abad-Zapatero C; Cho S
    ACS Infect Dis; 2019 Jun; 5(6):829-840. PubMed ID: 30990022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of small-molecule modulators for ClpP protease activity.
    Ye F; Li J; Yang CG
    Mol Biosyst; 2016 Dec; 13(1):23-31. PubMed ID: 27831584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel class of Plasmodial ClpP protease inhibitors as potential antimalarial agents.
    Mundra S; Thakur V; Bello AM; Rathore S; Asad M; Wei L; Yang J; Chakka SK; Mahesh R; Malhotra P; Mohmmed A; Kotra LP
    Bioorg Med Chem; 2017 Oct; 25(20):5662-5677. PubMed ID: 28917450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthetic Interrogation of Soil Metagenomes Reveals Metamarin, an Uncommon Cyclomarin Congener with Activity against
    Li L; MacIntyre LW; Ali T; Russo R; Koirala B; Hernandez Y; Brady SF
    J Nat Prod; 2021 Apr; 84(4):1056-1066. PubMed ID: 33621083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total Synthesis of Cyclomarin A, a Marine Cycloheptapeptide with Anti-Tuberculosis and Anti-Malaria Activity.
    Barbie P; Kazmaier U
    Org Lett; 2016 Jan; 18(2):204-7. PubMed ID: 26699807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the N-terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions.
    Wolf NM; Lee H; Zagal D; Nam JW; Oh DC; Lee H; Suh JW; Pauli GF; Cho S; Abad-Zapatero C
    Acta Crystallogr D Struct Biol; 2020 May; 76(Pt 5):458-471. PubMed ID: 32355042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of New Compounds Active against Plasmodium falciparum by High Throughput Screening of Microbial Natural Products.
    Pérez-Moreno G; Cantizani J; Sánchez-Carrasco P; Ruiz-Pérez LM; Martín J; El Aouad N; Pérez-Victoria I; Tormo JR; González-Menendez V; González I; de Pedro N; Reyes F; Genilloud O; Vicente F; González-Pacanowska D
    PLoS One; 2016; 11(1):e0145812. PubMed ID: 26735308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli.
    Tasdemir D; Topaloglu B; Perozzo R; Brun R; O'Neill R; Carballeira NM; Zhang X; Tonge PJ; Linden A; Rüedi P
    Bioorg Med Chem; 2007 Nov; 15(21):6834-45. PubMed ID: 17765547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A natural product based DOS library of hybrid systems.
    Prabhu G; Agarwal S; Sharma V; Madurkar SM; Munshi P; Singh S; Sen S
    Eur J Med Chem; 2015 May; 95():41-8. PubMed ID: 25794788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolopyrimidine inhibitors of 2-methylerythritol 2,4-cyclodiphosphate synthase (IspF) from Mycobacterium tuberculosis and Plasmodium falciparum.
    Geist JG; Lauw S; Illarionova V; Illarionov B; Fischer M; Gräwert T; Rohdich F; Eisenreich W; Kaiser J; Groll M; Scheurer C; Wittlin S; Alonso-Gómez JL; Schweizer WB; Bacher A; Diederich F
    ChemMedChem; 2010 Jul; 5(7):1092-101. PubMed ID: 20480490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.